128 related articles for article (PubMed ID: 34008339)
1. Activated mast cells in skeletal muscle can be a potential mediator for cancer-associated cachexia.
Widner DB; Liu C; Zhao Q; Sharp S; Eber MR; Park SH; Files DC; Shiozawa Y
J Cachexia Sarcopenia Muscle; 2021 Aug; 12(4):1079-1097. PubMed ID: 34008339
[TBL] [Abstract][Full Text] [Related]
2. Hepatic signal transducer and activator of transcription-3 signalling drives early-stage pancreatic cancer cachexia via suppressed ketogenesis.
Arneson-Wissink PC; Mendez H; Pelz K; Dickie J; Bartlett AQ; Worley BL; Krasnow SM; Eil R; Grossberg AJ
J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):975-988. PubMed ID: 38632714
[TBL] [Abstract][Full Text] [Related]
3. Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse.
Aulino P; Berardi E; Cardillo VM; Rizzuto E; Perniconi B; Ramina C; Padula F; Spugnini EP; Baldi A; Faiola F; Adamo S; Coletti D
BMC Cancer; 2010 Jul; 10():363. PubMed ID: 20615237
[TBL] [Abstract][Full Text] [Related]
4. Increased myocellular lipid and IGFBP-3 expression in a pre-clinical model of pancreatic cancer-related skeletal muscle wasting.
Cole CL; Bachman JF; Ye J; Murphy J; Gerber SA; Beck CA; Boyce BF; Muthukrishnan G; Chakkalakal JV; Schwarz EM; Linehan D
J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):731-745. PubMed ID: 33960737
[TBL] [Abstract][Full Text] [Related]
5. Withaferin A ameliorates ovarian cancer-induced cachexia and proinflammatory signaling.
Straughn AR; Kakar SS
J Ovarian Res; 2019 Nov; 12(1):115. PubMed ID: 31767036
[TBL] [Abstract][Full Text] [Related]
6. Modeling Human Cancer-induced Cachexia.
Talbert EE; Cuitiño MC; Ladner KJ; Rajasekerea PV; Siebert M; Shakya R; Leone GW; Ostrowski MC; Paleo B; Weisleder N; Reiser PJ; Webb A; Timmers CD; Eiferman DS; Evans DC; Dillhoff ME; Schmidt CR; Guttridge DC
Cell Rep; 2019 Aug; 28(6):1612-1622.e4. PubMed ID: 31390573
[TBL] [Abstract][Full Text] [Related]
7. Establishment and characterization of a novel murine model of pancreatic cancer cachexia.
Michaelis KA; Zhu X; Burfeind KG; Krasnow SM; Levasseur PR; Morgan TK; Marks DL
J Cachexia Sarcopenia Muscle; 2017 Oct; 8(5):824-838. PubMed ID: 28730707
[TBL] [Abstract][Full Text] [Related]
8. Inflammation-associated intramyocellular lipid alterations in human pancreatic cancer cachexia.
Deng M; Cao J; van der Kroft G; van Dijk DPJ; Aberle MR; Grgic A; Neumann UP; Wiltberger G; Balluff B; Schaap FG; Heeren RMA; Olde Damink SWM; Rensen SS
J Cachexia Sarcopenia Muscle; 2024 May; ():. PubMed ID: 38725139
[TBL] [Abstract][Full Text] [Related]
9. Modelling three-dimensional cancer-associated cachexia and therapy: The molecular basis and therapeutic potential of interleukin-6 transignalling blockade.
Cosentino M; Forcina L; Zouhair M; Apa L; Genovese D; Boccia C; Rizzuto E; Musarò A
J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2550-2568. PubMed ID: 37727078
[TBL] [Abstract][Full Text] [Related]
10. Transcutaneous carbon dioxide suppresses skeletal muscle atrophy in a mouse model of oral squamous cell carcinoma.
Sasaki A; Takeda D; Kawai H; Tadokoro Y; Murakami A; Yatagai N; Arimoto S; Nagatsuka H; Akashi M; Hasegawa T
PLoS One; 2024; 19(4):e0302194. PubMed ID: 38630690
[TBL] [Abstract][Full Text] [Related]
11. Cancer-Cachexia-Induced Human Skeletal Muscle Myotube Degeneration Is Prevented via Cannabinoid Receptor 2 Agonism In Vitro.
Noone J; Rooney MF; Karavyraki M; Yates A; O'Sullivan SE; Porter RK
Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004445
[TBL] [Abstract][Full Text] [Related]
12. Profiling of Adipose and Skeletal Muscle in Human Pancreatic Cancer Cachexia Reveals Distinct Gene Profiles with Convergent Pathways.
Narasimhan A; Zhong X; Au EP; Ceppa EP; Nakeeb A; House MG; Zyromski NJ; Schmidt CM; Schloss KNH; Schloss DEI; Liu Y; Jiang G; Hancock BA; Radovich M; Kays JK; Shahda S; Couch ME; Koniaris LG; Zimmers TA
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33923976
[TBL] [Abstract][Full Text] [Related]
13. Human Cachexia Induces Changes in Mitochondria, Autophagy and Apoptosis in the Skeletal Muscle.
de Castro GS; Simoes E; Lima JDCC; Ortiz-Silva M; Festuccia WT; Tokeshi F; Alcântara PS; Otoch JP; Coletti D; Seelaender M
Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31466311
[TBL] [Abstract][Full Text] [Related]
14. Transcriptomic signature of cancer cachexia by integration of machine learning, literature mining and meta-analysis.
Zhao K; Ebrahimie E; Mohammadi-Dehcheshmeh M; Lewsey MG; Zheng L; Hoogenraad NJ
Comput Biol Med; 2024 Apr; 172():108233. PubMed ID: 38452471
[TBL] [Abstract][Full Text] [Related]
15. The complex heterogeneity of immune cell signatures across wasting tissues with C26 and 5-fluorouracil-induced cachexia.
VanderVeen BN; Cardaci TD; Bullard BM; Huss AR; McDonald SJ; Muhammed AD; Kubinak JL; Fan D; Murphy EA
Am J Physiol Cell Physiol; 2024 Feb; 326(2):C606-C621. PubMed ID: 38189130
[TBL] [Abstract][Full Text] [Related]
16. Differentially expressed alternatively spliced genes in skeletal muscle from cancer patients with cachexia.
Narasimhan A; Greiner R; Bathe OF; Baracos V; Damaraju S
J Cachexia Sarcopenia Muscle; 2018 Feb; 9(1):60-70. PubMed ID: 28984045
[TBL] [Abstract][Full Text] [Related]
17. Exploring the Therapeutic Potential of Ethyl 3-Hydroxybutyrate in Alleviating Skeletal Muscle Wasting in Cancer Cachexia.
Zhou Y; Lu R; Lin F; Chen S; He QQ; Wu G; Huang C; Lin D
Biomolecules; 2023 Aug; 13(9):. PubMed ID: 37759730
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of weight loss and transcriptomic signatures in pancreatic ductal adenocarcinoma.
Riner AN; Herremans KM; Vudatha V; Han S; Qu X; Liu J; Mukhopadhyay N; Freudenberger DC; George TJ; Judge SM; Judge AR; Hughes SJ; Trevino JG
J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):149-158. PubMed ID: 38123146
[TBL] [Abstract][Full Text] [Related]
19. Gait speed is a biomarker of cancer-associated cachexia decline and recovery.
Roy I; Binder-Markey B; Sychowski D; Willbanks A; Phipps T; McAllister D; Bhakta A; Marquez E; D'Andrea D; Franz C; Pichika R; Dwinell MB; Jayabalan P; Lieber RL
bioRxiv; 2023 Nov; ():. PubMed ID: 38014165
[TBL] [Abstract][Full Text] [Related]
20. Identification of circulating plasma ceramides as a potential sexually dimorphic biomarker of pancreatic cancer-induced cachexia.
Chakedis JM; Dillhoff ME; Schmidt CR; Rajasekera PV; Evans DC; Williams TM; Guttridge DC; Talbert EE
JCSM Rapid Commun; 2022; 5(2):254-265. PubMed ID: 36591536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
